Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bentall

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Oxford Medical Case Reports|June 23, 2017
Early eculizumab use in atypical haemolytic uraemic syndrome in a Jehovah's Witness refusing blood productsMay Al-Shaghana, Andrew Bentall, Mark D Jesky, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2016
Predicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody DataManuel Moreno Gonzales, Andrew Bentall, Walter K Kremers, et al.
Oxford Medical Case Reports|September 26, 2018
Multi-system bleeding risk with a cutaneous angiosarcoma at an arteriovenous fistula siteDominic Heining, Jonathan Senior, Abheesh Prasad, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|February 8, 2012
Sickle cell and renal transplant: a national survey and literature reviewJay Nath, James McDaid, Andrew Bentall, et al.
Transplantation|February 5, 2014
No progress in ABO titer measurement: time to aim for a reference?Andrew Bentall, Fiona Regan, Jenny White, et al.
Transplantation Direct|December 15, 2022
Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and RetransplantationSuryanarayanan Balakrishnan, Byron Smith, Andrew Bentall, et al.
Human Immunology|February 23, 2021
Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?Jiqiu Wen, Arpita Basu, Andrew Bentall, et al.
Transplantation|February 26, 2019
Use of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post-kidney Transplantation: A Consecutive Series of 15 CasesEk Khoon Tan, Andrew Bentall, Patrick G Dean, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 25, 2019
Ultrastructural changes in pulmonary allografts with antibody-mediated rejectionMariam P Alexander, Andrew Bentall, Patrice C Abell Aleff, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 18, 2020
Role of symmetric dimethylarginine in predicting future renal impairment in liver transplant recipientsManhal Izzy, Mounika Angirekula, Andrew Bentall, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Oxford Medical Case Reports|June 23, 2017
Early eculizumab use in atypical haemolytic uraemic syndrome in a Jehovah's Witness refusing blood productsMay Al-Shaghana, Andrew Bentall, Mark D Jesky, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2016
Predicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody DataManuel Moreno Gonzales, Andrew Bentall, Walter K Kremers, et al.
Oxford Medical Case Reports|September 26, 2018
Multi-system bleeding risk with a cutaneous angiosarcoma at an arteriovenous fistula siteDominic Heining, Jonathan Senior, Abheesh Prasad, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|February 8, 2012
Sickle cell and renal transplant: a national survey and literature reviewJay Nath, James McDaid, Andrew Bentall, et al.
Transplantation|February 5, 2014
No progress in ABO titer measurement: time to aim for a reference?Andrew Bentall, Fiona Regan, Jenny White, et al.
Transplantation Direct|December 15, 2022
Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and RetransplantationSuryanarayanan Balakrishnan, Byron Smith, Andrew Bentall, et al.
Human Immunology|February 23, 2021
Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?Jiqiu Wen, Arpita Basu, Andrew Bentall, et al.
Transplantation|February 26, 2019
Use of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post-kidney Transplantation: A Consecutive Series of 15 CasesEk Khoon Tan, Andrew Bentall, Patrick G Dean, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 25, 2019
Ultrastructural changes in pulmonary allografts with antibody-mediated rejectionMariam P Alexander, Andrew Bentall, Patrice C Abell Aleff, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 18, 2020
Role of symmetric dimethylarginine in predicting future renal impairment in liver transplant recipientsManhal Izzy, Mounika Angirekula, Andrew Bentall, et al.
Pageof 4